SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ACHV

Achieve Life Sciences Inc.
NASDAQHealth Care

Latest close: 6.38 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 19, 2026Reported sale · Form 4Richard Alistair Stewart · $175.2KOpen the filing ↗
  3. Aug 19, 2026Notice of sale · Form 144Stewart Richard Alistair · Director · $155.1KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,20319 flagged findings
Reported transactions (Form 4)80since Apr 21, 2023 · and 32 other holdings
Corporate events (8-K)30since Apr 27, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…Agreement with the Investors, pursuant to which we agreed to sell and issue to the Investors in a private placement (the “Private…”
    +1 more passage from the same document
    • “…Pre-Funded Warrants to purchase up to 100,500 Pre-Funded Warrant Shares, and (ii) Common Warrants to purchase up to 49,518,569…”
  • 2026-05-12share offering or dilution eventrecentOpen filing ↗
    “…placement, we issued unregistered warrants to purchase up to 13,086,151 shares of common stock at an exercise price of $ 4.906 per…”
    +1 more passage from the same document
    • “…price of $ 3.00 per share and accompanying warrant, less underwriting discounts and commissions. Pursuant to the Underwriting…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,203)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 6, 26Form 4 ↗Insider transaction
  • Oct 6, 26Form 3 ↗Insider transaction
  • Oct 1, 268-K ↗Current report · A senior executive left or was appointed
  • Aug 21, 26Form 4 ↗Insider transaction
  • Aug 19, 26Form 144 ↗Notice of proposed sale
  • Aug 17, 26SCHEDULE 13G ↗Passive stake · Logos Global Management LP · 10.0% · event on May 11, 26
  • Aug 14, 268-K ↗Current report · Other events
  • Aug 14, 26424B5 ↗Securities offering
  • Aug 13, 26SCHEDULE 13G ↗Passive stake · JANUS HENDERSON GROUP Ltd. · 5.4% · event on Jun 30, 26
  • Aug 11, 2610-Q ↗Quarterly report
  • Aug 11, 268-K ↗Current report · Results
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Jul 28, 26SCHEDULE 13G/A ↗Passive stake · Franklin Resources, Inc. · 8.3% · event on Jun 30, 26 · amendment
  • Jul 27, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.1% · event on Jun 30, 26
  • Jul 8, 26SCHEDULE 13G ↗Passive stake · Vivo Opportunity, LLC · 5.0% · event on Jul 6, 26
  • Jul 6, 268-K ↗Current report · Bylaws or fiscal year change · Shareholder vote results
  • Jun 8, 26DEF 14A ↗Shareholder meeting and votes
  • Jun 2, 26Form 4 ↗Insider transaction
  • Jun 2, 26Form 3 ↗Insider transaction

1,203 filings on record, the oldest from May 24, 96.

Listing the 25 most recent filings of the 1,203 on record.

8-Ks, explained

Stress14Structure75Governance44
  • Governance3 senior executive changes2026show all 3hide
    • Oct 1, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 2, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 12, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 16, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Oct 7, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 11, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 27, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 10, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 9, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 27, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Aug 26, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 29, 24StructureTook on a new financial obligation+3 more in the same filing8-K 2.03 ↗
  • Feb 29, 24StructureSold unregistered shares+5 more in the same filing8-K 3.02 ↗
  • May 25, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

7 older filings not shown · The record reaches back to Sep 20, 04.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Nov 25, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 24, 20StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Feb 28, 17StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 17, 16StressRestructuring plan with committed costs8-K 2.05 ↗
  • Oct 28, 16StressRestructuring plan with committed costs8-K 2.05 ↗
  • Aug 22, 16StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Feb 26, 16StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Feb 4, 16StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Aug 21, 08StressRestructuring plan with committed costs+8 more in the same filing8-K 2.05 ↗
  • May 9, 08StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗

The full record holds 14 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • TPG GP A, LLC12.6%Apr 17, 25SCHEDULE 13D ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • venBio Global Strategic Fund V, L.P.10.0%Apr 15, 26SCHEDULE 13D ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Logos Global Management LP10.0%May 11, 26SCHEDULE 13G ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
  • Paradigm BioCapital Advisors LP9.2%Apr 17, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Franklin Resources, Inc.8.3%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Frazier Life Sciences Public Fund, L.P.6.5%Apr 17, 26SCHEDULE 13G ↗9 co-filers on this document — the figure is the largest single stake, not their sum.
  • Alyeska Investment Group, L.P.5.6%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 5 more holdershide
  • JANUS HENDERSON GROUP Ltd.5.4%Jun 30, 26SCHEDULE 13G ↗
  • Venrock Healthcare Capital Partners III, L.P.5.2%Apr 17, 26SCHEDULE 13G ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
  • BlackRock, Inc.5.1%Jun 30, 26SCHEDULE 13G ↗1 earlier filing
  • Vivo Opportunity, LLC5.0%Jul 6, 26SCHEDULE 13G ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
  • Parker Quillen4.9%Sep 30, 25SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 19, Stewart Richard Alistair filed notice of intent to sell up to $155K. That is about 0.02% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $175K on Aug 19, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 19, 26Sell$175KRichard Alistair Stewart↗
  • Sep 18, 25Sell$378KRichard Alistair StewartChief Executive Officer↗
  • Sep 18, 25Sell$146KMark K OkiChief Financial Officer↗
  • Sep 4, 25Sell$58KJaime XinosChief Commercial Officer↗
  • Sep 4, 25Sell$77KCINDY JACOBSPresident & CMO↗
  • Sep 4, 25Sell$387KTHOMAS BRAXTON KING↗
  • Sep 4, 25Sell$39KJerry WanPrincipal Accounting Officer↗
  • Mar 17, 25Buy$29KRichard Alistair StewartChieve Executive Officer↗
  • Mar 17, 25Buy$29KMark K OkiChief Financial Officer↗
  • Mar 4, 24Buy$46KJohn BencichCEO↗
  • Mar 4, 24Buy$46KRichard Alistair StewartExecutive Chairman↗
  • May 30, 23Buy$28KJohn BencichCEO↗
Stock compensation, tax and giftsshow the 28 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 18, 25Compensationamount n/aRichard Alistair StewartChief Executive Officer↗
  • Sep 18, 25Compensationamount n/aMark K OkiChief Financial Officer↗
  • Sep 4, 25Compensationamount n/aJaime XinosChief Commercial Officer↗
  • Sep 4, 25Compensationamount n/aCINDY JACOBSPresident & CMO↗
  • Sep 4, 25Compensationamount n/aTHOMAS BRAXTON KING↗
  • Sep 4, 25Compensationamount n/aJerry WanPrincipal Accounting Officer↗
  • Aug 16, 24Compensation$18KJohn BencichCEO↗
  • Aug 16, 24Compensation$10KCINDY JACOBSPresident & CMO↗
  • Aug 16, 24Compensation$10KJerry WanPrincipal Accounting Officer↗
  • Apr 19, 24Compensationamount n/aJohn BencichCEO↗
  • Apr 19, 24Tax$27KJohn BencichCEO↗
  • Apr 19, 24Compensationamount n/aRichard Alistair StewartExecutive Chairman↗
  • Apr 19, 24Tax$46KRichard Alistair StewartExecutive Chairman↗
  • Apr 19, 24Compensationamount n/aCINDY JACOBSPresident & CMO↗
  • Apr 19, 24Tax$18KCINDY JACOBSPresident & CMO↗
  • Apr 19, 24Compensationamount n/aJerry WanPrincipal Accounting Officer↗
  • Apr 19, 24Tax$10KJerry WanPrincipal Accounting Officer↗
  • Apr 28, 23Compensationamount n/aRichard Alistair StewartExecutive Chairman↗
  • Apr 28, 23Tax$19KRichard Alistair StewartExecutive Chairman↗
  • Apr 28, 23Compensationamount n/aJohn BencichCEO↗
  • Apr 28, 23Tax$15KJohn BencichCEO↗
  • Apr 28, 23Compensationamount n/aCINDY JACOBSPresident & CMO↗
  • Apr 28, 23Tax$5KCINDY JACOBSPresident & CMO↗
  • Apr 28, 23Compensationamount n/aJerry WanPrincipal Accounting Officer↗
  • Apr 28, 23Tax$6KJerry WanPrincipal Accounting Officer↗
  • Apr 21, 23Compensationamount n/aRichard Alistair StewartExecutive Chairman↗
  • Apr 21, 23Tax$69KRichard Alistair StewartExecutive Chairman↗
  • Apr 21, 23Compensationamount n/aJerry WanPrincipal Accounting Officer↗

The full record holds 45 transactions and goes back to Jan 25, 23.

Its sector and its market

Achieve Life Sciences Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Achieve Life Sciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Achieve Life Sciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,203 documents on file, from May 24, 1996 to Oct 6, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.